Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma

Oncogene volume 22, pages 5399–5407 (2003)Cite this article

Abstract

Signal transducer and activator of transcription 3 (STAT3), normally activated by Janus kinase (JAK) in response to cytokine stimulation, has been shown to have oncogenic potential. In addition to JAK, recent data suggest that STAT3 can also be activated by other proteins such as the aberrant fusion protein, NPM-ALK, which is expressed in a subset of systemic anaplastic large cell lymphoma (ALCL). In this study, we investigated the possible role of JAK in activating STAT3 in ALCL using two ALK-positive ALCL cell lines, Karpas 299 and SU-DHL-1. At the steady state, JAK3 showed detectable tyrosine phosphorylation by immunoprecipitation. Treatment with AG490, a JAK inhibitor, decreased but did not completely abrogate tyrosine phosphorylation of JAK3 and STAT3 in a concentration-dependent manner. Similar results were obtained using two other inhibitors of JAK3, WHI-P131 and WHI-P154. These biochemical changes were associated with apoptosis in both cell lines that was coupled with activation of caspase 3 and decreased bcl-xL and bcl-2. Cell cycle analysis revealed a decrease in the S phase, which may be attributed to cyclin D3 downregulation and p21waf1 upregulation. Importantly, the tyrosine kinase activity of NPM-ALK, as assessed by an in vitro assay, decreased with increasing concentrations of AG490. Our findings highlight the importance of JAK3 in activating STAT3 in ALCL, and that NPM-ALK-mediated activation of STAT3 is influenced by the functional status of JAK3.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10

Similar content being viewed by others

References

  • Alas S and Bonavida B . (2001). Cancer Res., 61, 5137–5144.

  • Altieri DC . (2001). Trends Mol. Med., 7, 542–547.

  • Aoki Y, Feldman GM and Tosato G . (2003). Blood, 101, 1535–1542.

  • Bai RY, Dieter P, Peschel C, Morris SW and Duyster J . (1998). Mol. Cell. Biol., 18, 6951–6961.

    Article  CAS  Google Scholar 

  • Bai RY, Ouyang T, Miething C, Morris SW, Peschel C and Duyster J . (2000). Blood, 96, 4319–4327.

  • Bischof D, Pulford K, Mason DY and Morris SW . (1997). Mol. Cell. Biol., 17, 2312–2325.

    Article  CAS  Google Scholar 

  • Borer RA, Lehner CF, Eppenberger HM and Nigg EA . (1989). Cell, 56, 379–390.

    Article  CAS  Google Scholar 

  • Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA and Jove R . (2001). Proc. Natl. Acad. Sci. USA, 98, 7319–7324.

  • Bromberg J . (2002). J. Clin. Invest., 109, 1139–1142.

    Article  CAS  Google Scholar 

  • Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE . (1999). Cell, 98, 295–303.

    Article  CAS  Google Scholar 

  • Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK and Lin J . (2001). Oncogene, 20, 7925–7934.

    Article  CAS  Google Scholar 

  • Coqueret O and Gascan H . (2000). J. Biol. Chem., 275, 18794–18800.

    Article  CAS  Google Scholar 

  • Delsol G, Ralfkiaer E, Stein H, Wright D and Jaffe E . (2001). Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours Jaffe E, Harris N, Stein H and Vardiman J (eds) IARC Press: Lyon, France, pp. 230–235.

    Google Scholar 

  • Epling-Burnette PK, Liu JH, Catlett-Falcone R, Turkson J, Oshiro M, Kothapalli R, Li Y, Wang JM, Yang-Yen HF, Karras J, Jove R and Loughran Jr TP . (2001a). J. Clin. Invest., 107, 351–362.

    Article  CAS  Google Scholar 

  • Epling-Burnette PK, Zhong B, Bai F, Jiang K, Bailey RD, Garcia R, Jove R, Djeu JY, Loughran Jr TP and Wei S . (2001b). J. Immunol., 166, 7486–7495.

  • Epstein AL and Kaplan HS . (1974). Cancer, 34, 1851–1872.

    Article  CAS  Google Scholar 

  • Eriksen KW, Kaltoft K, Mikkelsen G, Nielsen M, Zhang Q, Geisler C, Nissen MH, Ropke C, Wasik MA and Odum N . (2001). Leukemia, 15, 787–793.

    Article  CAS  Google Scholar 

  • Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, Verhoef G, Menestrina F, Todeschini G, Paulli M, Lazzarino M, Giardini R, Aiello A, Foss HD, Araujo I, Fizzotti M, Pelicci PG, Flenghi L, Martelli MF and Santucci A . (1999). Blood, 93, 2697–2706.

  • Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S and Yamamoto T . (1996). Proc. Natl. Acad. Sci. USA, 93, 4181–4186.

  • Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M and Hirano T . (1998). EMBO J., 17, 6670–6677.

  • Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, Morris SW, Connors JM, Vose JM, Viswanatha DS, Coldman A and Weisenburger DD . (1999). Blood, 93, 3913–3921.

  • Grad JM, Zeng XR and Boise LH . (2000). Curr. Opin. Oncol., 12, 543–549.

  • Huang M, Page C, Reynolds RK and Lin J . (2000). Gynecol. Oncol., 79, 67–73.

  • Imada K and Leonard WJ . (2000). Mol. Immunol., 37, 1–11.

  • Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S and Grandis JR . (2002). Cell Growth Differ., 13, 355–362.

  • Kirken RA, Erwin-Cohen R, Behbod F, Wang M, Stepkowski SM and Kahan BD . (2001). Transplant Proc., 33, 95.

  • Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I, Heinrich PC, Diehl V and Tesch H . (2001). Blood, 98, 762–770.

    Article  CAS  Google Scholar 

  • Levy DE and Darnell Jr JE . (2002). Nat. Rev. Mol. Cell. Biol., 3, 651–662.

  • Liu J and Kern JA . (2002). Am. J. Respir. Cell Mol. Biol., 27, 306–313.

  • Ma Z, Cools J, Marynen P, Cui X, Siebert R, Gesk S, Schlegelberger B, Peeters B, De Wolf-Peeters C, Wlodarska I and Morris SW . (2000). Blood, 95, 2144–2149.

  • Mahboubi K, Li F, Plescia J, Kirkiles-Smith NC, Mesri M, Du Y, Carroll JM, Elias JA, Altieri DC and Pober JS . (2001). Lab. Invest., 81, 327–334.

  • Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T and Akira S . (1996). Proc. Natl. Acad. Sci. USA, 93, 3963–3966.

  • Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R and Cleary ML . (1989). Blood, 73, 2155–2164.

  • Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL and Look AT . (1994). Science, 263, 1281–1284.

    Article  CAS  Google Scholar 

  • Naka T, Matsumoto T, Narazaki M, Fujimoto M, Morita Y, Ohsawa Y, Saito H, Nagasawa T, Uchiyama Y and Kishimoto T . (1998). Proc. Natl. Acad. Sci. USA, 95, 15577–15582.

  • Narla RK, Liu XP, Klis D and Uckun FM . (1998). Clin. Cancer Res., 4, 2463–2471.

  • Nielsen M, Kaltoft K, Nordahl M, Ropke C, Geisler C, Mustelin T, Dobson P, Svejgaard A and Odum N . (1997). Proc. Natl. Acad. Sci. USA, 94, 6764–6769.

  • Ning ZQ, Li J, McGuinness M and Arceci RJ . (2001). Oncogene, 20, 4528–4536.

    Article  CAS  Google Scholar 

  • Pulford K, Morris SW and Mason DY . (2001). Curr. Opin. Hematol., 8, 231–236.

  • Rane SG and Reddy EP . (2002). Oncogene, 21, 3334–3358.

    Article  CAS  Google Scholar 

  • Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T and Mori S . (1995). Blood, 86, 1954–1960.

  • Slupianek A, Nieborowska-Skorska M, Hoser G, Morrione A, Majewski M, Xue L, Morris SW, Wasik MA and Skorski T . (2001). Cancer Res., 61, 2194–2199.

  • Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R and Lennert K . (1985). Blood, 66, 848–858.

  • Sudbeck EA, Liu XP, Narla RK, Mahajan S, Ghosh S, Mao C and Uckun FM . (1999). Clin. Cancer Res., 5, 1569–1582.

  • Sun X, Layton JE, Elefanty A and Lieschke GJ . (2001). Blood, 97, 2008–2015.

  • Turturro F, Frist AY, Arnold MD, Seth P and Pulford K . (2001). Oncogene, 20, 4466–4475.

    Article  CAS  Google Scholar 

  • Uckun FM, Ek O, Liu XP and Chen CL . (1999). Clin. Cancer Res., 5, 2954–2962.

  • Wang LH, Kirken RA, Erwin RA, Yu C-R and Farrar WL . (1999). J. Immunol., 162, 3897–3904.

  • Wei LH, Kuo ML, Chen CA, Chou CH, Cheng WF, Chang MC, Su JL and Hsieh CY . (2001). Oncogene, 20, 5799–5809.

    Article  CAS  Google Scholar 

  • Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M, Levy DE and Inghirami G . (2002). Oncogene, 21, 1038–1047.

    Article  CAS  Google Scholar 

  • Zhang Q, Raghunath PN, Xue L, Majewski M, Carpentieri DF, Odum N, Morris S, Skorski T and Wasik MA . (2002). J. Immunol., 168, 466–474.

Download references

Author information

Authors and Affiliations

  1. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA

    Hesham M Amin, L Jeffrey Medeiros, Yupo Ma, Marianna Feretzaki, Pamela Das, Vasiliki Leventaki, George Z Rassidakis & Raymond Lai

  2. Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, 77030, TX, USA

    Sean L O'Connor & Timothy J McDonnell

Authors
  1. Hesham M Amin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Jeffrey Medeiros
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yupo Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marianna Feretzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pamela Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vasiliki Leventaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. George Z Rassidakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sean L O'Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Timothy J McDonnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Raymond Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raymond Lai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amin, H., Medeiros, L., Ma, Y. et al. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene 22, 5399–5407 (2003). https://doi.org/10.1038/sj.onc.1206849

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206849

Keywords

This article is cited by

Search

Advanced search

Quick links